Reply to 'Re: Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'

Bart Geboers^{1

2

3}, Matthijs J V Scheltema^{1

2

4}, Louise Emmett^{1

5}, Phillip D Stricker^{1

2}

Affiliations

¹ Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.
² St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia.
³ Department of Radiology and Nuclear Medicine, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands.
⁴ Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
⁵ Department of Theranostics and Nuclear Medicine, St. Vincent's, Hospital, Sydney, New South Wales, Australia.

Comment

Bart Geboers et al. BJU Int. 2024 Apr.

. 2024 Apr:133 Suppl 4:25-26.

doi: 10.1111/bju.16308. Epub 2024 Feb 28.

Bart Geboers^{1

2

3}, Matthijs J V Scheltema^{1

2

4}, Louise Emmett^{1

5}, Phillip D Stricker^{1

2}

¹ Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.
² St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia.
³ Department of Radiology and Nuclear Medicine, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands.
⁴ Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
⁵ Department of Theranostics and Nuclear Medicine, St. Vincent's, Hospital, Sydney, New South Wales, Australia.

No abstract available

Conflict of interest statement

None declared.

Re: 'Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'.
Guercio A, Franco G, Lombardo R, De Nunzio C. Guercio A, et al. BJU Int. 2024 Apr;133 Suppl 4:23-24. doi: 10.1111/bju.16263. Epub 2024 Jan 4. BJU Int. 2024. PMID: 38098312 No abstract available.

1. Guercio A, Franco G, Lombardo R, De Nunzio C. Re: ‘Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy’. BJU Int. 2023 Dec 14. https://doi.org/10.1111/bju.16263. Online ahead of print
1. Geboers B, Meijer D, Counter W et al. Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy. BJU Int 2023
1. Emmett L, Buteau J, Papa N et al. The additive diagnostic value of prostate‐specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. Eur Urol 2021; 80: 682–689
1. Blazevski A, Scheltema MJ, Yuen B et al. Oncological and quality‐of‐life outcomes following focal irreversible electroporation as Primary treatment for localised prostate cancer: a biopsy‐monitored prospective cohort. Eur Urol Oncol 2020; 3: 283–290
1. Thompson JE, Moses D, Shnier R et al. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol 2014; 192: 67–74